Call for Applications

Call for Applications Now Open!

KHI is now accepting applications to serve on its Board of Directors (BOD). Newly appointed BOD members would serve a three-year term starting January 1, 2024, renewable for one additional term. All BOD members serve through the Biologics, Devices, Drugs, or Strategy Committees.

The organizational structure of KHI includes a diverse and balanced BOD that reflects the stakeholders and members. For 2023, the KHI BOD seeks the following candidate profiles for the Biologics, Devices, Drugs, and Strategy Committees:

  • Representatives from small, mid, and large-sized private sector companies that encompass the breadth of FDA's mission
  • Health professionals with expertise in kidney diseases (and are members of the American Society for Nephrology)
  • At-large representatives with diverse experiences developing kidney biologics, devices and drugs

Applications must be received by Tuesday, October 10, 2023, at 5:00 p.m. EDT and specify which KHI BOD committee the candidate intends to serve on.